Nugen Medical Devices Inc (NGMD.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 181 | 238 | 125 | 139 | 151 |
| Income taxes - deferred | 0 | 1 | 0 | 0 | 2 |
| Accounts receivable | -82 | -31 | 223 | -39 | -91 |
| Accounts payable and accrued liabilities | -278 | 727 | -399 | 399 | -116 |
| Other Working Capital | -1,123 | 852 | -396 | 484 | -336 |
| Other Operating Activity | -746 | -1,699 | -66 | -1,536 | -764 |
| Operating Cash Flow | $-2,048 | $88 | $-513 | $-552 | $-1,154 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -32 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 2,397 | 45 | 628 | 0 | 0 |
| Other Financing Activity | 0 | -159 | 0 | 0 | 0 |
| Financing Cash Flow | $2,365 | $-114 | $628 | $0 | $0 |
| Exchange Rate Effect | 5 | -35 | -10 | 35 | 10 |
| Beginning Cash Position | 131 | 193 | 87 | 605 | 1,750 |
| End Cash Position | 453 | 131 | 193 | 87 | 605 |
| Net Cash Flow | $317 | $-27 | $115 | $-552 | $-1,154 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,048 | 88 | -513 | -552 | -1,154 |
| Free Cash Flow | -2,048 | 88 | -513 | -552 | -1,154 |